Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Investigational New Drugs
|
June 4, 2025
A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors
Nai-Jung Chiang, Li-Yuan Bai, I-Wei Ho, et al.
Annals of Hematology
|
April 26, 2024
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations
Yu-Cheng Chang, Hui-Jen Tsai, To-Yu Huang, et al.
The Lancet. Oncology
|
July 13, 2026
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
Ming Gao, Young Joo Park, Chia-Chi Lin, et al.
The Oncologist
|
December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
Ming-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
European Journal of Haematology
|
June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma
Hui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Scientific Reports
|
July 16, 2021
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
Yan-Shen Shan, Li-Tzong Chen, Chih-Hsing Wu, et al.
Scientific Reports
|
September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
Hui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 11, 2022
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)
Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, et al.
Journal of Biomedical Science
|
February 13, 2024
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
Siao Muk Cheng, Yung-Yeh Su, Nai-Jung Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC
Chia-Ming Yeh, Chih-Chuan Yu, An-Fu Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Investigational New Drugs
|
June 4, 2025
A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors
Nai-Jung Chiang, Li-Yuan Bai, I-Wei Ho, et al.
Annals of Hematology
|
April 26, 2024
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations
Yu-Cheng Chang, Hui-Jen Tsai, To-Yu Huang, et al.
The Lancet. Oncology
|
July 13, 2026
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
Ming Gao, Young Joo Park, Chia-Chi Lin, et al.
The Oncologist
|
December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
Ming-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
European Journal of Haematology
|
June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma
Hui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Scientific Reports
|
July 16, 2021
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
Yan-Shen Shan, Li-Tzong Chen, Chih-Hsing Wu, et al.
Scientific Reports
|
September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
Hui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 11, 2022
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)
Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, et al.
Journal of Biomedical Science
|
February 13, 2024
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
Siao Muk Cheng, Yung-Yeh Su, Nai-Jung Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC
Chia-Ming Yeh, Chih-Chuan Yu, An-Fu Lee, et al.
Page
of 7